EP 230043WO01 EP 23186053.7 2023-07-18 Novo Nordisk A/S PHARMACEUTICAL COMPOSITIONS OF INSULIN DERIVATIVES 6 21 AA PAT source 1..21 mol_type protein organism Homo sapiens GIVEQCCTSICSLYQLENYCN 30 AA PAT source 1..30 mol_type protein organism Homo sapiens FVNQHLCGSHLVEALYLVCGERGFFYTPKT 29 AA PAT source 1..29 mol_type protein organism synthetic construct FVNQHLCGSHLVEALYLVCGERGFFYTPK 47 AA PAT source 1..47 mol_type protein organism synthetic construct GKPGGGGSGGGGSGGGGSFVNQHLCGSHLVEALYLVCGERGFFYTPK 71 AA PAT source 1..71 mol_type protein organism synthetic construct GKPEGEQPGEQPGEQPGEQPGEQGGKPEGGGSGGGGSGGGGSFVNQHLCGSHLVEALYLVCGERGFFYTPK 42 AA PAT source 1..42 mol_type protein organism synthetic construct GKPEGEQPGEQPGEQPGEQPGEQGGKPEGGGSGGGGSGGGGS